Robert F. Kennedy Jr., President-elect Donald Trump’s nominee for Secretary of Health and Human Services, earned approximately $10.7 million in 2023, with much of his income stemming from his work with various law firms and his leadership of a vaccine-skeptic nonprofit. According to recently amended financial disclosures filed as part of his presidential campaign, Kennedy also holds significant assets, including between $500,001 and $1 million in Bitcoin and commercial real estate in Chicago worth hundreds of thousands of dollars.
Congressional leaders revealed a stopgap funding bill on Tuesday to keep the government operational until March 14, setting off a race to pass the legislation by the end of the week.
During Thursday's episode of The View, co-host Whoopi Goldberg accused Health and Human Services (HHS) nominee Robert F. Kennedy Jr. of fat-shaming Americans by advocating for healthy lifestyle choices over weight-loss drugs. The exchange followed Kennedy’s comments to CNBC’s Jim Cramer, where he suggested that Americans should prioritize diet and exercise before resorting to GLP-1 medications like Ozempic and Mounjaro.
Efforts to transfer control of the land where the former RFK Stadium sits to Washington, D.C., could soon come to fruition through an unconventional legislative strategy. According to a report from Punchbowl News, the legislation may be included in a continuing resolution to fund the federal government, which lawmakers must pass by December 20 to avoid a government shutdown.
President-elect Donald Trump’s transition team is unveiling the "Make America Healthy Again" (MAHA) initiative, spotlighting a lineup of bold reformers slated to lead the nation’s healthcare overhaul. Trump’s Cabinet picks are positioned to tackle bureaucracy, corruption, and America’s rising chronic disease rates, with a focus on transparency and competition.
Several of the senators set to vote on Robert F. Kennedy Jr.'s appointment to lead the Department of Health and Human Services (HHS) have received donations from pharmaceutical companies.
